EMDR Therapy in Young Children, a Double-blinded Randomized Controlled Trial

Recruiting now · Not applicable

Conditions studied: Trauma, Psychological, Stress, Psychological, Anxiety Disorders

In brief

This project aims to answer to the question of EMDR effectiveness in young children and to determine whether or not the therapy effectiveness is related to the level of cognitive functioning in young children. The study requires a total of 60 children, girls and boys, aged 3 to 6 years and presenting disorders related to stressors, anxiety and/or trauma. Participants will be randomly distributed in two groups: "EMDR therapy" (N=30) group or "control therapy" (N=30) group. The study will take place in four stages: 1/ Pre-treatment phase : An evaluation of child's various cognitive and executive functions, child's symptomatology and parental distress is planned in a pre-treatment phase. 2/ Treatment phase : An EMDR therapy or a routine care is administered to the child between 6 to 10 weeks. 3/ Post-treatment phase : A reassessment of child's and parent's symptoms is planned at the end of treatment. 4/ Continuation of treatment: Children who have received control therapy and without symptomatic improvement will be proposed EMDR treatment. These children will receive the same symptomatic assessments at the end of EMDR treatment. A significant reduction in disorders related to trauma or stress and anxiety factors and their symptomatology, as well as comorbid disorders and their symptomatology, is expected in children who received EMDR therapy compared to the group who received a control therapy. These results are expected to be robust over a period of at least 3 months. The positive effects of EMDR on child symptomatology are also expected to be more pronounced in children showing higher levels of cognitive functioning

Key facts

Study ID

NCT05419934

Run by

Fondation Lenval

People needed

60

Starts

2022-09-27

Expected to finish

2025-12-01

Last updated by the study team

2025-04-01

Who can join

Age: 3 and older, up to 6. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Child aged 3 to 6 at the time of inclusion;
• Established diagnosis of one or more disorders related to a trauma or a stress factor, and/or an anxiety disorder, assessed by the Diagnostic Infant and Preschool Assessment (DIPA) diagnostic tool
• Typical language

You may not qualify if…

• Child taking a psychotropic treatment
• Suicidal intentions or ideation of the main caregivers, or of the child, and self-harming behavior;
• Parent(s) or care figure(s) with a substance use disorder;
• Presence or diagnosis of specific pathological conditions in the child (neurodevelopmental disorders based on Diagnostic and Statistical Manual of Mental Disorders (DSM V) criteria, brain trauma, or neurological pathology);
• Participation of the child in another biomedical research on the psychic care of disorders related to trauma or stress and anxiety factors

Where it is running

• Hôpitaux Pédiatriques de Nice CHU-Lenval — Nice, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.